4/A
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001705477-26-000002
Options or other derivatives
- Chief Financial Officer acquired 48,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nofi Michael · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-12 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +48,750 | 48,750 | D |
Loading xslF345X06/primarydocument.xml…